Gauge of Risk | GenomeWeb

Gauge of Risk

One company says it will soon be offering a DNA-based suicide risk test, Technology Review reports.

Sundance Diagnostics plans to offer its saliva-based test, which is based on research out of the Max Planck Institute of Psychiatry, to doctors beginning next month for patients taking anti-depressants like Prozac or Zoloft. People just beginning anti-depressant treatment are sometimes at increased risk of suicide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.